haloperidol has been researched along with Syndrome in 95 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We randomized cannabis users with active emesis to either haloperidol (with a nested randomization to either 0." | 9.41 | Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial. ( Crawford, FM; Day, AG; Forrester, S; Hall, AK; Ruberto, AJ; Sivilotti, MLA, 2021) |
| "We studied the relationship between the efficiency of muscarinic receptor antagonists in preventing haloperidol-induced catatonia and their activity in tests for the interaction of ligands with various subtypes of muscarinic receptors (M1-M4) in rats." | 7.72 | Effect of M4-cholinoceptor blockade on haloperidol-produced catatonic syndrome in rats. ( Beliaev, VA; Dagaev, SG; Dolgo-Saburov, VB; Filko, OA; Khrabrova, AV; Kosmachev, AB; Kubarskaya, LG; Libman, NM; Podosinovikova, NP; Sanotskii, VI, 2004) |
| "We report on three patients with acute coronary syndromes who developed QT interval prolongation associated with intravenous haloperidol use." | 7.70 | Corrected QT interval prolongation associated with intravenous haloperidol in acute coronary syndromes. ( Block, PC; Douglas, PH, 2000) |
| "The development of school phobia has been reported in some patients with Tourette syndrome treated with haloperidol." | 7.67 | Tourette syndrome, pimozide, and school phobia: the neuroleptic separation anxiety syndrome. ( Linet, LS, 1985) |
| " Intravenous lorazepam was rapidly effective in reversing the catatonia and attendant symptoms." | 7.66 | Intravenous lorazepam in neuroleptic-induced catatonia. ( Cassem, NH; Fricchione, GL; Hobson, D; Hooberman, D, 1983) |
| " The patient had unusual, life-threatening complications, consisting of cardiac arrhythmia, followed by cardiac arrest, dysphagia persisting for eight weeks and leading to aspiration pneumonia, seizures, and myoclonus following treatment with haloperidol." | 7.66 | Neuroleptic malignant syndrome after haloperidol therapy. ( Cruz, FG; Harney, JH; Thiagarajan, D, 1983) |
| "An unusual, acute extrapyramidal reaction, which resulted from treatment with haloperidol and which was unresponsive to standard anticholinergic treatment and indistinguishable on clinical grounds from acute catatonia, is described." | 7.65 | Catatonia and malignant syndrome: a possible complication of neuroleptic administration. Report of a case involving haloperidol. ( Kelly, MJ; Weinberger, DR, 1977) |
| "We randomized cannabis users with active emesis to either haloperidol (with a nested randomization to either 0." | 5.41 | Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial. ( Crawford, FM; Day, AG; Forrester, S; Hall, AK; Ruberto, AJ; Sivilotti, MLA, 2021) |
| "Further, neither catalepsy intensity nor its latency was affected by a combination of the selective A(1)R antagonist DPCPX (1 mg/kg), with the larger doses of both anticholinergics." | 5.36 | Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: a potential treatment for extrapyramidal syndromes. ( Arankowsky-Sandoval, G; Ceballos-Huerta, F; Góngora-Alfaro, JL; González-Lugo, OE; Jiménez-Capdeville, ME, 2010) |
| "Charles Bonnet syndrome is an underrecognized condition characterized by complex visual hallucinations, ocular problems causing visual deterioration and preserved cognitive status." | 5.35 | [Charles Bonnet syndrome: report of one case managed with haloperidol]. ( Franco, JG; Valencia, C, 2008) |
| "Catalepsy was measured in rats using both the cross-legged position test and the bar test." | 5.31 | Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy. ( Colpaert, FC; Kleven, MS; Koek, W; Prinssen, EP, 2000) |
| "The encephalopathy was worsened by hyperthermia, dehydration, and reintroduction of haloperidol, 5 days after the first discontinuation of the neuroleptic." | 5.30 | [Acute encephalomyopathy and persistent cerebellar syndrome after lithium salt and haloperidol poisoning]. ( de Barsy, T; Delbecq, J; Depré, A; Ghariani, S; Gille, M; Piéret, F; Saussu, F, 1997) |
| "Malignant syndrome is a disease characterized by high fever, extrapyramidal syndrome and dysautonomia recognized during or at the time of stopping administration of antipsychotic medication and it is the most severe and lethal side effect of antipsychotic medication." | 5.30 | [A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine]. ( Fujimoto, K; Konishi, K; Kubota, M; Ogawa, H, 1997) |
| " The syndrome resolved within a few days of stopping haloperidol and initiation of lorazepam." | 3.78 | Neuroleptic-induced catatonia in two hospitalized patients. ( Gugger, JJ; Saad, M; Smith, C, 2012) |
| "We studied the relationship between the efficiency of muscarinic receptor antagonists in preventing haloperidol-induced catatonia and their activity in tests for the interaction of ligands with various subtypes of muscarinic receptors (M1-M4) in rats." | 3.72 | Effect of M4-cholinoceptor blockade on haloperidol-produced catatonic syndrome in rats. ( Beliaev, VA; Dagaev, SG; Dolgo-Saburov, VB; Filko, OA; Khrabrova, AV; Kosmachev, AB; Kubarskaya, LG; Libman, NM; Podosinovikova, NP; Sanotskii, VI, 2004) |
| "We report on three patients with acute coronary syndromes who developed QT interval prolongation associated with intravenous haloperidol use." | 3.70 | Corrected QT interval prolongation associated with intravenous haloperidol in acute coronary syndromes. ( Block, PC; Douglas, PH, 2000) |
| " The same is true for parkinsonian and "malignant locomotion" syndromes provoked by intrastriatal pro-oxidant (oxidized oleinic acid) microinjection and systemic administration of haloperidol." | 3.69 | [The role of lipid peroxidation in the pathogenesis of neuropathological syndromes and in experimental therapy]. ( Aliev, AN; Aliev, MN; Mamedbeĭli, TN; Rzaev, RN, 1994) |
| "To study a correlation between anxiety and delirium, 50 schizophrenic patients with the anxiety-delirious syndrome were treated with anxiolytics (leponex and phenazepam)." | 3.67 | [Structure of the anxious-delusional syndrome of schizophrenic patients during treatment with anxiolytics]. ( Nuller, IuL; Vasil'ev, AA, 1986) |
| "After receiving 90 mg of haloperidol and 100 mg of chlorpromazine hydrochloride within 25 hours, a 29-year-old man was found to have neuroleptic malignant syndrome (NMS), characterized by the acute onset of hyperpyrexia, extreme muscular rigidity, autonomic instability, and coma." | 3.67 | Neuroleptic malignant syndrome and dopaminergic blockade. ( Hashimoto, F; Jeffery, WH; Sherman, CB, 1984) |
| "From among 1377 patients with movement disorders, four patients had an unusual movement disorder characterised by paroxysmal bursts of involuntary, regular, repetitive, rhythmic, bilateral, coordinated, simultaneous, stereotypic myoclonus and vocalisations, often associated with tonic symptoms, interference with voluntary functioning, presence of hyperactivity, attention and learning disabilities, and resistance to treatment with haloperidol and other drugs." | 3.67 | Paroxysmal myoclonic dystonia with vocalisations: new entity or variant of preexisting syndromes? ( Feinberg, TE; Shapiro, AK; Shapiro, E, 1986) |
| "We present extrapyramidal syndrome in 22 children (5 en 1984 and 17 during 1985) who received clebopride (15), metoclopramide (6) and haloperidol (1), almost all at the level of therapeutic doses, which fact seems to indicated a idiosyncratic factor." | 3.67 | [Drug-induced extrapyramidal syndrome. Apropos of 22 cases]. ( Calvo Fernández, J; Castro-Gago, M; Couce Pico, M; López Rois, F; Novo, I, 1987) |
| "The development of school phobia has been reported in some patients with Tourette syndrome treated with haloperidol." | 3.67 | Tourette syndrome, pimozide, and school phobia: the neuroleptic separation anxiety syndrome. ( Linet, LS, 1985) |
| "Neuroleptic malignant syndrome and acute myoglobinuric renal failure developed in three patients after they had received a combination of a major tranquilizer and a tricyclic antidepressant or after a large dose of haloperidol." | 3.66 | Acute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndrome. ( Eiser, AR; Neff, MS; Slifkin, RF, 1982) |
| " Intravenous lorazepam was rapidly effective in reversing the catatonia and attendant symptoms." | 3.66 | Intravenous lorazepam in neuroleptic-induced catatonia. ( Cassem, NH; Fricchione, GL; Hobson, D; Hooberman, D, 1983) |
| " The patient had unusual, life-threatening complications, consisting of cardiac arrhythmia, followed by cardiac arrest, dysphagia persisting for eight weeks and leading to aspiration pneumonia, seizures, and myoclonus following treatment with haloperidol." | 3.66 | Neuroleptic malignant syndrome after haloperidol therapy. ( Cruz, FG; Harney, JH; Thiagarajan, D, 1983) |
| "26 patients with a paranoid-hallucinatory syndrome were treated with a fixed daily dose of haloperidol." | 3.65 | Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol. ( Ackenheil, M; Eben, E; Hippius, H; Rüther, E; Schilkrut, R, 1976) |
| "An unusual, acute extrapyramidal reaction, which resulted from treatment with haloperidol and which was unresponsive to standard anticholinergic treatment and indistinguishable on clinical grounds from acute catatonia, is described." | 3.65 | Catatonia and malignant syndrome: a possible complication of neuroleptic administration. Report of a case involving haloperidol. ( Kelly, MJ; Weinberger, DR, 1977) |
| "Fluperlapine (NB-106-689) was tested on 26 schizophrenic patients in an open and crossover study." | 2.66 | Differential effects of a new dibenzo-epine neuroleptic compared with haloperidol. Results of an open and crossover study. ( Bartels, M; Gärtner, HJ; Heimann, H; Mann, K; Schied, HW; Wagner, W, 1987) |
| "The drug difference between a low and a high dosage of haloperidol was investigated in 40 acutely ill schizophrenic patients." | 2.65 | Effects of high and low dosage of haloperidol on the brain in relation to schizophrenic thought disorder. ( Lehmann, E; Scholz, OB; Winter, M, 1984) |
| " Ironically, chronic use of cannabis can result in paradoxical effects, including a condition known as cannabinoid hyperemesis syndrome." | 2.61 | Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting. ( Forest, CP; Smith, TN; Walsh, A, 2019) |
| "Hemichorea is a disorder characterized by abnormal, continuous, nonrhythmic, jerky, and distal movement involving one side of the body." | 1.43 | Hemichorea with unilateral MRI striatal hyperintensity in a Saudi patient with diabetes. ( Al-Quliti, KW; Assaedi, ES, 2016) |
| "Further, neither catalepsy intensity nor its latency was affected by a combination of the selective A(1)R antagonist DPCPX (1 mg/kg), with the larger doses of both anticholinergics." | 1.36 | Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: a potential treatment for extrapyramidal syndromes. ( Arankowsky-Sandoval, G; Ceballos-Huerta, F; Góngora-Alfaro, JL; González-Lugo, OE; Jiménez-Capdeville, ME, 2010) |
| "Choreoathetotic syndromes are frequently observed in children after congenital cardiopathy surgery." | 1.36 | Late-onset choreoathetotic syndrome following heart surgery. ( Alessandrini, F; Avesani, M; Bertolasi, L; Bovi, P; Buffone, CE; Moretto, G; Musso, A; Ottaviani, S; Passarin, MG; Petrilli, G; Romito, S; Santini, F, 2010) |
| "Hyperventilation syndrome has often occurred as a reaction to anxiety and stress." | 1.35 | [Hyperventilation syndrome before induction of and after awakening from general anesthesia]. ( Hanaoka, K; Honda, M; Itou, Y; Mizuno, J; Momoeda, K; Morita, S, 2009) |
| "Charles Bonnet syndrome is an underrecognized condition characterized by complex visual hallucinations, ocular problems causing visual deterioration and preserved cognitive status." | 1.35 | [Charles Bonnet syndrome: report of one case managed with haloperidol]. ( Franco, JG; Valencia, C, 2008) |
| "Catalepsy was measured in rats using both the cross-legged position test and the bar test." | 1.31 | Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy. ( Colpaert, FC; Kleven, MS; Koek, W; Prinssen, EP, 2000) |
| "Malignant syndrome is a disease characterized by high fever, extrapyramidal syndrome and dysautonomia recognized during or at the time of stopping administration of antipsychotic medication and it is the most severe and lethal side effect of antipsychotic medication." | 1.30 | [A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine]. ( Fujimoto, K; Konishi, K; Kubota, M; Ogawa, H, 1997) |
| "The encephalopathy was worsened by hyperthermia, dehydration, and reintroduction of haloperidol, 5 days after the first discontinuation of the neuroleptic." | 1.30 | [Acute encephalomyopathy and persistent cerebellar syndrome after lithium salt and haloperidol poisoning]. ( de Barsy, T; Delbecq, J; Depré, A; Ghariani, S; Gille, M; Piéret, F; Saussu, F, 1997) |
| " We discuss a possible relation between serotonin syndrome and a highly dosed combination therapy with moclobemide." | 1.29 | [Depressive stupor--malignant neuroleptic syndrome--serotonin syndrome. A case contribution to a difficult differential diagnosis]. ( König, F; Löble, M; Wolfersdorf, M, 1996) |
| "We observed a case of NMS in which disseminated intravascular coagulation was a prominent feature." | 1.27 | Neuroleptic malignant syndrome complicated by disseminated intravascular coagulation. ( DiPette, DJ; Eles, GR; Songer, JE, 1984) |
| "Patients with paranoid schizophrenia display fully or partially unstable circadian rhythms." | 1.27 | [Treatment of paranoid schizophrenia taking circadian biological rhythms into account]. ( Tsaritsinskiĭ, VI, 1984) |
| "Akathisia is a common but frequently unrecognized complication of antipsychotic medication." | 1.27 | Akathisia: the syndrome of motor restlessness. ( Friedman, JH; Wagner, RL, 1987) |
| "It was found that in patients with Tourette's syndrome PAG excretion with the urine was lowered, the degree of this lowering being independent of the patients' age, sex, and nourishment." | 1.26 | [Early diagnosis of the Tourette syndrome]. ( Khaĭlova, IM; Khokhlov, AP; Mel'nichuk, PV, 1980) |
| "The syndrome was not seen after thioridazine (3-7 mg/kg)." | 1.26 | Acute dystonia as an idiosyncratic response to neuroleptics in baboons. ( Anlezark, GM; Marsden, CD; Meldrum, BS, 1977) |
| "Tremor was seen in 26 of 30 patients being mild in 12, moderate in 11, and severe in three." | 1.26 | Dystonia and tremor in spasmodic torticollis. ( Couch, JR, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 54 (56.84) | 18.7374 |
| 1990's | 14 (14.74) | 18.2507 |
| 2000's | 14 (14.74) | 29.6817 |
| 2010's | 10 (10.53) | 24.3611 |
| 2020's | 3 (3.16) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, JM | 1 |
| Wilsey, MJ | 1 |
| Dhana, L | 1 |
| Lonsdale, H | 1 |
| Ruberto, AJ | 2 |
| Sivilotti, MLA | 2 |
| Forrester, S | 1 |
| Hall, AK | 2 |
| Crawford, FM | 2 |
| Day, AG | 1 |
| Smith, TN | 1 |
| Walsh, A | 1 |
| Forest, CP | 1 |
| Hernández-Ramos, I | 1 |
| Parra-Esquivel, P | 1 |
| López-Hernández, Á | 1 |
| Burillo-Putze, G | 1 |
| Hickey, JL | 1 |
| Witsil, JC | 1 |
| Mycyk, MB | 1 |
| Gortney, JS | 1 |
| Raub, JN | 1 |
| Patel, P | 1 |
| Kokoska, L | 1 |
| Hannawa, M | 1 |
| Argyris, A | 1 |
| Al-Quliti, KW | 1 |
| Assaedi, ES | 1 |
| Inayat, F | 1 |
| Virk, HU | 1 |
| Ullah, W | 1 |
| Hussain, Q | 1 |
| Valencia, C | 1 |
| Franco, JG | 1 |
| Mizuno, J | 1 |
| Morita, S | 1 |
| Itou, Y | 1 |
| Honda, M | 1 |
| Momoeda, K | 1 |
| Hanaoka, K | 1 |
| Passarin, MG | 1 |
| Romito, S | 1 |
| Avesani, M | 1 |
| Alessandrini, F | 1 |
| Petrilli, G | 1 |
| Santini, F | 1 |
| Bertolasi, L | 1 |
| Musso, A | 1 |
| Buffone, CE | 1 |
| Ottaviani, S | 1 |
| Bovi, P | 1 |
| Moretto, G | 1 |
| González-Lugo, OE | 1 |
| Ceballos-Huerta, F | 1 |
| Jiménez-Capdeville, ME | 1 |
| Arankowsky-Sandoval, G | 1 |
| Góngora-Alfaro, JL | 1 |
| Nguyen, H | 2 |
| Le, C | 1 |
| Gugger, JJ | 1 |
| Saad, M | 1 |
| Smith, C | 1 |
| AZIMA, H | 1 |
| DUROST, H | 1 |
| ARTHURS, D | 1 |
| CAPRINI, G | 1 |
| MELOTTI, V | 1 |
| BORENSTEIN, P | 1 |
| DABBAH, M | 1 |
| BLES, G | 1 |
| BOISSIER, JR | 1 |
| SIMON, P | 1 |
| VOLMAT, R | 1 |
| BEAUDOUIN, JL | 1 |
| COLLIN, J | 1 |
| NICOLAS-CHARLES, PJ | 1 |
| ALLERS, G | 1 |
| LURIA, E | 1 |
| RIZZUTO, N | 1 |
| PERINI, U | 1 |
| LAMPO, B | 1 |
| Awata, S | 1 |
| Dagaev, SG | 2 |
| Kosmachev, AB | 1 |
| Filko, OA | 1 |
| Kubarskaya, LG | 2 |
| Khrabrova, AV | 2 |
| Beliaev, VA | 1 |
| Podosinovikova, NP | 1 |
| Libman, NM | 1 |
| Sanotskii, VI | 2 |
| Dolgo-Saburov, VB | 2 |
| Fil'ko, OA | 1 |
| Mukovskii, LA | 1 |
| Glukhova, RI | 1 |
| Walloch, JE | 1 |
| Klauwer, C | 1 |
| Lanczik, M | 1 |
| Brockington, IF | 1 |
| Kornhuber, J | 1 |
| Wehrschuetz, M | 1 |
| Simbrunner, J | 1 |
| Enzinger, C | 1 |
| Ebner, F | 1 |
| Praharaj, SK | 1 |
| Arora, M | 1 |
| Cesario, V | 1 |
| Henderson, VW | 1 |
| Wooten, GF | 1 |
| Eiser, AR | 1 |
| Neff, MS | 1 |
| Slifkin, RF | 1 |
| Bjørndal, N | 1 |
| Remvig, J | 1 |
| Gottlieb, P | 1 |
| Fricchione, GL | 1 |
| Cassem, NH | 1 |
| Hooberman, D | 1 |
| Hobson, D | 1 |
| Stoudemire, A | 1 |
| Luther, JS | 1 |
| Watanabe, N | 1 |
| Moroji, T | 1 |
| Tada, K | 1 |
| Aoki, N | 1 |
| Cope, RV | 1 |
| Gregg, EM | 1 |
| Gower, AJ | 1 |
| Berendsen, HG | 1 |
| Princen, MM | 1 |
| Broekkamp, CL | 1 |
| Winter, M | 1 |
| Lehmann, E | 1 |
| Scholz, OB | 1 |
| Yasukawa, M | 1 |
| Hatakeyama, Y | 1 |
| Yasukawa, K | 1 |
| Chiba, S | 1 |
| Suzuki, T | 1 |
| Takami, T | 1 |
| Tsaritsinskiĭ, VI | 1 |
| Hashimoto, F | 1 |
| Sherman, CB | 1 |
| Jeffery, WH | 1 |
| Mosketi, KV | 1 |
| Mokhovikov, AN | 1 |
| Aksent'ev, SB | 1 |
| Goĭkhberg, IG | 1 |
| Kryzhanovskiĭ, GN | 2 |
| Eles, GR | 1 |
| Songer, JE | 1 |
| DiPette, DJ | 1 |
| Yoshii, F | 1 |
| Ishihara, T | 1 |
| Shinohara, Y | 1 |
| Nomura, K | 1 |
| Takagi, A | 1 |
| May, DC | 1 |
| Morris, SW | 1 |
| Stewart, RM | 1 |
| Fenton, BJ | 1 |
| Gaffney, FA | 1 |
| Dosani, RA | 1 |
| Cruz, FG | 1 |
| Thiagarajan, D | 1 |
| Harney, JH | 1 |
| Samar, RK | 1 |
| Kaushik, SK | 1 |
| Garg, AR | 1 |
| Skorga, P | 1 |
| Nunnery, C | 1 |
| Mel'nichuk, PV | 1 |
| Khokhlov, AP | 1 |
| Khaĭlova, IM | 1 |
| Town, IG | 1 |
| Soejima, A | 1 |
| Saito, M | 1 |
| Kitamoto, K | 1 |
| Nagasawa, T | 1 |
| Aliev, MN | 2 |
| Rzaev, RN | 1 |
| Mamedbeĭli, TN | 1 |
| Aliev, AN | 1 |
| Marchlewski, MB | 1 |
| Gay, J | 1 |
| Losa, JE | 1 |
| Iglesias-Osma, C | 1 |
| Ortín, A | 1 |
| König, F | 1 |
| Löble, M | 1 |
| Wolfersdorf, M | 1 |
| Konishi, K | 1 |
| Fujimoto, K | 1 |
| Kubota, M | 1 |
| Ogawa, H | 1 |
| Gille, M | 1 |
| Ghariani, S | 1 |
| Piéret, F | 1 |
| Delbecq, J | 1 |
| Depré, A | 1 |
| Saussu, F | 1 |
| de Barsy, T | 1 |
| Iakimovskiĭ, AF | 1 |
| Hess-Röver, J | 1 |
| Crichton, J | 1 |
| Byrne, K | 1 |
| Holland, AJ | 1 |
| Kornreich, C | 1 |
| Dan, B | 1 |
| Verbanck, P | 1 |
| Pelc, I | 1 |
| Douglas, PH | 1 |
| Block, PC | 1 |
| Prinssen, EP | 1 |
| Koek, W | 1 |
| Colpaert, FC | 1 |
| Kleven, MS | 1 |
| Damodaran, SS | 1 |
| Thankamma, JK | 1 |
| Benítez del Rosario, MA | 1 |
| Montón, F | 1 |
| Salinas, A | 1 |
| Martín, JJ | 1 |
| Feria, M | 1 |
| Marilov, VV | 1 |
| Hardy-Baylé, MC | 1 |
| Meldrum, BS | 1 |
| Anlezark, GM | 1 |
| Marsden, CD | 1 |
| Rosenstock, HA | 1 |
| Vincent, KR | 1 |
| Matuk, F | 1 |
| Kalyanaraman, K | 1 |
| Weinberger, DR | 1 |
| Kelly, MJ | 1 |
| Couch, JR | 1 |
| Rüther, E | 2 |
| Schilkrut, R | 2 |
| Ackenheil, M | 2 |
| Eben, E | 2 |
| Hippius, H | 2 |
| Granacher, RP | 1 |
| Baldessarini, RJ | 1 |
| Suzuki, E | 1 |
| Kanba, S | 1 |
| Nibuya, M | 1 |
| Shintani, F | 1 |
| Kinoshita, N | 1 |
| Yagi, G | 1 |
| Asai, M | 1 |
| Nisijima, K | 1 |
| Hirayama, M | 1 |
| Decina, P | 1 |
| Caracci, G | 1 |
| Scapicchio, PL | 1 |
| Kondo, T | 1 |
| Tamaya, S | 1 |
| Ohta, Y | 1 |
| Yamabayashi, H | 1 |
| Vasil'ev, AA | 1 |
| Nuller, IuL | 1 |
| Friedman, JH | 1 |
| Wagner, RL | 1 |
| Russell, KH | 1 |
| Hagenmeyer-Houser, SH | 1 |
| Sanberg, PR | 1 |
| Mann, K | 1 |
| Bartels, M | 1 |
| Gärtner, HJ | 1 |
| Schied, HW | 1 |
| Wagner, W | 1 |
| Heimann, H | 1 |
| Amore, M | 1 |
| Cerisoli, M | 1 |
| Campanile, S | 1 |
| Campanile, A | 1 |
| Janati, A | 1 |
| Davidson, M | 1 |
| Powchik, P | 1 |
| Davis, KL | 1 |
| Feinberg, TE | 1 |
| Shapiro, AK | 1 |
| Shapiro, E | 1 |
| López Rois, F | 1 |
| Couce Pico, M | 1 |
| Calvo Fernández, J | 1 |
| Novo, I | 1 |
| Castro-Gago, M | 1 |
| Linet, LS | 1 |
| Avrutskii, GIa | 1 |
| Gurovich, IIa | 1 |
| Prokhorova, IS | 1 |
| Tirkel'taub, IuA | 1 |
| Romanov, IuD | 1 |
| Traczyńska-Kubin, H | 1 |
| Matkowska, L | 1 |
| Jeffries, JJ | 1 |
| Lefebvre, A | 1 |
| Sichko, ZhV | 1 |
| Budanova, LF | 1 |
| Gracheva, IV | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Droperidol on Prevention of Emesis From Cannabinoid Hyperemesis Syndrome[NCT05244460] | Phase 3 | 45 participants (Anticipated) | Interventional | 2021-12-02 | Recruiting | ||
| Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized Controlled Trial[NCT03056482] | Phase 4 | 33 participants (Actual) | Interventional | 2017-05-21 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for haloperidol and Syndrome
| Article | Year |
|---|---|
Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting.
Topics: Acute Disease; Antiemetics; Cannabinoids; Haloperidol; Humans; Lorazepam; Nausea; Syndrome; Vomiting | 2019 |
Alcohol withdrawal syndrome in medical patients.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antagonists; Alcohol Withdrawal Delirium; Alco | 2016 |
[Acute brain syndrome].
Topics: Acute Disease; Antipsychotic Agents; Delirium; Diagnostic and Statistical Manual of Mental Disorders | 2003 |
Delusional denial of pregnancy as a special form of Cotard's syndrome: case report and review of the literature.
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Delusions; Denial, Psychological; Doxepin; Femal | 2007 |
Diagnosis and treatment of a severe psychotic illness in a man with dual severe sensory impairments caused by the presence of Usher syndrome.
Topics: Animals; Antipsychotic Agents; Blindness; Cricetinae; Diagnosis, Differential; Genetic Predispositio | 1999 |
3 trials available for haloperidol and Syndrome
| Article | Year |
|---|---|
Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
Topics: Administration, Intravenous; Adult; Antiemetics; Female; Haloperidol; Humans; Male; Marijuana Abuse; | 2021 |
Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
Topics: Administration, Intravenous; Adult; Antiemetics; Female; Haloperidol; Humans; Male; Marijuana Abuse; | 2021 |
Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
Topics: Administration, Intravenous; Adult; Antiemetics; Female; Haloperidol; Humans; Male; Marijuana Abuse; | 2021 |
Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
Topics: Administration, Intravenous; Adult; Antiemetics; Female; Haloperidol; Humans; Male; Marijuana Abuse; | 2021 |
Effects of high and low dosage of haloperidol on the brain in relation to schizophrenic thought disorder.
Topics: Hallucinations; Haloperidol; Hostility; Humans; Hypochondriasis; Schizophrenia; Schizophrenia, Paran | 1984 |
Differential effects of a new dibenzo-epine neuroleptic compared with haloperidol. Results of an open and crossover study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Depression; Dibenzazepines; F | 1987 |
87 other studies available for haloperidol and Syndrome
| Article | Year |
|---|---|
Acute Treatment of Adolescent Cannabinoid Hyperemesis Syndrome With Haloperidol, Lorazepam, and/or Capsaicin: A Single Institution Case Series.
Topics: Adolescent; Adult; Cannabinoids; Capsaicin; Child; Haloperidol; Humans; Lorazepam; Nausea; Syndrome; | 2023 |
Topics: Cannabis; Haloperidol; Humans; Ondansetron; Syndrome; Vomiting | 2021 |
[Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome].
Topics: Antiemetics; Cannabinoids; Capsaicin; Haloperidol; Humans; Male; Marijuana Abuse; Mediastinal Emphys | 2019 |
Haloperidol for treatment of cannabinoid hyperemesis syndrome.
Topics: Abdominal Pain; Adult; Antiemetics; Cannabinoids; Haloperidol; Humans; Male; Marijuana Abuse; Nausea | 2013 |
Hemichorea with unilateral MRI striatal hyperintensity in a Saudi patient with diabetes.
Topics: Anti-Dyskinesia Agents; Chorea; Diabetes Complications; Diabetes Mellitus; Female; Haloperidol; Huma | 2016 |
Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?
Topics: Adult; Antiemetics; Cannabinoids; Haloperidol; Humans; Male; Marijuana Abuse; Nausea; Syndrome; Trea | 2017 |
[Charles Bonnet syndrome: report of one case managed with haloperidol].
Topics: Aged, 80 and over; Antipsychotic Agents; Diagnosis, Differential; Female; Hallucinations; Haloperido | 2008 |
[Hyperventilation syndrome before induction of and after awakening from general anesthesia].
Topics: Anesthesia, Epidural; Anesthesia, General; Antipsychotic Agents; Anxiety; Arthroplasty, Replacement, | 2009 |
Late-onset choreoathetotic syndrome following heart surgery.
Topics: Age of Onset; Anti-Dyskinesia Agents; Basal Ganglia; Brain Diseases; Cardiac Surgical Procedures; Ch | 2010 |
Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: a potential treatment for extrapyramidal syndromes.
Topics: Animals; Basal Ganglia Diseases; Catalepsy; Cholinergic Antagonists; Drug Synergism; Drug Therapy, C | 2010 |
Charles Bonnet syndrome in an elderly patient concurrent with acute cerebellar infarction treated successfully with haloperidol.
Topics: Aged; Brain Infarction; Cerebellar Diseases; Dopamine Antagonists; Hallucinations; Haloperidol; Huma | 2011 |
Neuroleptic-induced catatonia in two hospitalized patients.
Topics: Adult; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Hospitalization; | 2012 |
The effect of R-1625 (Haloperidol) in mental syndromes: a multiblind study.
Topics: Anesthesia; Electroconvulsive Therapy; Haloperidol; Hypnotics and Sedatives; Mental Disorders; Psych | 1960 |
[A severe tic syndrome cured with Haloperidol].
Topics: Anesthesia; Haloperidol; Hypnotics and Sedatives; Syndrome; Tics | 1962 |
[Apropos of the ultimate specificity of terrain in the appearance of extrapyramidal syndromes induced by neuroleptic agents].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Extrapyramidal Tracts; Haloperidol; Humans; Parkinson | 1962 |
[EXPERIMENTAL EQUIVALENTS OF THE NEUROLOGIC SYNDROME OF NEUROLEPTICS].
Topics: Antipsychotic Agents; Catalepsy; Catatonia; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Neuro | 1964 |
[COGENTINE (BTMS) IN THE TREATMENT OF NEUROLEPTIC SYNDROMES].
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Delirium; Depression; Hallucinations; Halope | 1964 |
[CONTRIBUTION TO THE STUDY OF A NEURODYSLEPTIC SYNDROME IN THE COURSE OF HALOPERIDOL THERAPY].
Topics: Antisocial Personality Disorder; Drug Therapy; Extrapyramidal Tracts; Haloperidol; Mental Disorders; | 1964 |
[HALOPERIDOL IN THE TREATMENT OF TIC SYNDROMES].
Topics: Adolescent; Child; Drug Therapy; Haloperidol; Humans; Syndrome; Tics | 1964 |
Effect of M4-cholinoceptor blockade on haloperidol-produced catatonic syndrome in rats.
Topics: Animals; Basal Ganglia Diseases; Catatonia; Haloperidol; Kinetics; Ligands; Male; Models, Biological | 2004 |
Effect of M2 muscarinic receptor blockade in rats with haloperidol-produced catatonic syndrome.
Topics: Animals; Catalepsy; Cyclopentanes; Diamines; Dopamine; Haloperidol; Male; Mandelic Acids; Muscarinic | 2004 |
[Hemiballism-hemichorea syndrome].
Topics: Anti-Dyskinesia Agents; Brain Diseases; Cerebrovascular Circulation; Chorea; Drug Therapy, Combinati | 2007 |
Pisa syndrome: acute and tardive forms.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dystonia; Haloperidol; Humans; Male; Schizoph | 2007 |
[Acute extrapyramidal syndrome and neuroleptical malignant syndrome. A case report].
Topics: Acute Disease; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Haloperidol; Humans; Injections, | 2008 |
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Body Temperature Regulation; Creatine Kinase; Fever; H | 1981 |
Acute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndrome.
Topics: Acute Kidney Injury; Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Dehydration; Fem | 1982 |
[Malignant neuroleptic syndrome].
Topics: Adult; Antipsychotic Agents; Blood Pressure; Body Temperature; Consciousness; Female; Haloperidol; H | 1983 |
Intravenous lorazepam in neuroleptic-induced catatonia.
Topics: Adult; Aged; Antipsychotic Agents; Catatonia; Female; Haloperidol; Humans; Injections, Intravenous; | 1983 |
Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Carbidopa; Catatonia; Diagnosis, Differential; F | 1984 |
A therapeutic trial of caerulein to a long-term heavy marihuana user with amotivational syndrome.
Topics: Adult; Brief Psychiatric Rating Scale; Ceruletide; Drug Therapy, Combination; Haloperidol; Humans; M | 1984 |
Neuroleptic malignant syndrome.
Topics: Adult; Basal Ganglia Diseases; Chlorpromazine; Haloperidol; Humans; Male; Syndrome | 1983 |
The yawning-penile erection syndrome as a model for putative dopamine autoreceptor activity.
Topics: Animals; Apomorphine; Drug Interactions; Haloperidol; Inhalation; Isomerism; Male; Models, Psycholog | 1984 |
[Neuroleptic malignant syndrome with myoglobinuria].
Topics: Basal Ganglia Diseases; Female; Haloperidol; Humans; Middle Aged; Myoglobinuria; Rhabdomyolysis; Sch | 1983 |
[Treatment of paranoid schizophrenia taking circadian biological rhythms into account].
Topics: Adolescent; Adult; Blood Pressure; Body Temperature; Circadian Rhythm; Delusions; Female; Hallucinat | 1984 |
Neuroleptic malignant syndrome and dopaminergic blockade.
Topics: Adult; Chlorpromazine; Dopamine; Haloperidol; Humans; Male; Muscular Diseases; Receptors, Dopamine; | 1984 |
[Complex use of phenazepam, lithium and haloperidol in the treatment of several forms of schizophrenia].
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Caudate Nucleus; D | 1984 |
Neuroleptic malignant syndrome complicated by disseminated intravascular coagulation.
Topics: Adult; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Disseminated Intravascular Coagula | 1984 |
[A case of malignant syndrome with persistent nystagmus and diplopia].
Topics: Adult; Diplopia; Female; Haloperidol; Humans; Lithium; Lithium Carbonate; Malignant Hyperthermia; Me | 1982 |
Neuroleptic malignant syndrome: response to dantrolene sodium.
Topics: Dantrolene; Fever; Haloperidol; Humans; Male; Middle Aged; Muscle Rigidity; Syndrome | 1983 |
Haloperidol-induced neuroleptic malignant syndrome.
Topics: Adult; Catatonia; Fever; Haloperidol; Humans; Male; Psychoses, Substance-Induced; Schizophrenia; Syn | 1983 |
Neuroleptic malignant syndrome after haloperidol therapy.
Topics: Deglutition Disorders; Haloperidol; Heart Arrest; Humans; Male; Middle Aged; Myoclonus; Pneumonia, A | 1983 |
Malignant neuroleptic syndrome due to haloperidol. (A case report).
Topics: Adult; Fever; Haloperidol; Humans; Male; Muscle Rigidity; Pallor; Syndrome | 1983 |
How to spot...and care for...the patient with Lown-Ganong-Levine syndrome.
Topics: Arrhythmias, Cardiac; Electrocardiography; Female; Haloperidol; Humans; Male; Middle Aged; Nursing A | 1981 |
[Early diagnosis of the Tourette syndrome].
Topics: Adolescent; Child; Female; Glutamine; Haloperidol; Humans; Male; Neurasthenia; Phenylacetates; Syndr | 1980 |
Haloperidol: neuroleptic malignant syndrome.
Topics: Adult; Dystonia; Haloperidol; Humans; Male; Muscle Rigidity; Syndrome | 1982 |
[Autopsy study of malignant syndrome with fatal acute renal failure].
Topics: Acute Kidney Injury; Autonomic Nervous System Diseases; Female; Haloperidol; Humans; Middle Aged; My | 1982 |
[The role of lipid peroxidation in the pathogenesis of neuropathological syndromes and in experimental therapy].
Topics: Animals; Antioxidants; Bemegride; Brain Chemistry; Chorea; Disease Models, Animal; Drug Evaluation, | 1994 |
Anticholinergic syndrome. Avoiding misdiagnosis.
Topics: Adolescent; Benztropine; Cholinergic Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Co | 1994 |
[Hemichorea-hemiballismus syndrome worsened by haloperidol].
Topics: Aged; Chorea; Female; Haloperidol; Humans; Hyperkinesis; Syndrome | 1994 |
[Depressive stupor--malignant neuroleptic syndrome--serotonin syndrome. A case contribution to a difficult differential diagnosis].
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzamides; Depressive Disorder; Diagnosis, | 1996 |
[A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine].
Topics: Adult; Antipsychotic Agents; Anxiety; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Chl | 1997 |
[Acute encephalomyopathy and persistent cerebellar syndrome after lithium salt and haloperidol poisoning].
Topics: Acute Disease; Adult; Antidepressive Agents; Antipsychotic Agents; Brain Diseases; Cerebellar Diseas | 1997 |
[Multiple microinjections of haloperidol in rat globus pallidus induce vegetative components of parkinsonian syndrome].
Topics: Animals; Autonomic Nervous System; Avoidance Learning; Dopamine Antagonists; Globus Pallidus; Halope | 1998 |
Treating Charles Bonnet syndrome: understanding inconsistency.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Hallucinations; Haloperidol; Humans; Male; Psychotic | 2000 |
Corrected QT interval prolongation associated with intravenous haloperidol in acute coronary syndromes.
Topics: Aged; Angina, Unstable; Antipsychotic Agents; Arrhythmias, Cardiac; Electrocardiography; Haloperidol | 2000 |
Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Behav | 2000 |
Reversal of rabbit syndrome with olanzapine.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Female; Haloperidol; Humans; M | 2000 |
Charles Bonnet syndrome and opioids.
Topics: Aged; Analgesics, Opioid; Antipsychotic Agents; Blindness; Diagnosis, Differential; Fatal Outcome; H | 2001 |
[The Dolittle syndrome].
Topics: Adult; Animals; Antipsychotic Agents; Birds; Cats; Female; Hallucinations; Haloperidol; Humans; Schi | 1997 |
[Manic syndrome: diagnostic trends and principles of treatment].
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chl | 1998 |
Acute dystonia as an idiosyncratic response to neuroleptics in baboons.
Topics: 5-Hydroxytryptophan; Acute Disease; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; H | 1977 |
[Pathogenesis of stereotyped behavior].
Topics: Animals; Behavior; Caudate Nucleus; Diazepam; Disease Models, Animal; gamma-Aminobutyric Acid; Halop | 1979 |
Capgras syndrome: case report of an adolescent and review of literature.
Topics: Adolescent; Body Image; Delusions; Female; Haloperidol; Humans; Object Attachment; Psychotic Disorde | 1978 |
Syndrome of inappropriate secretion of antidiuretic hormone in patients treated with psychotherapeutic drugs.
Topics: Adult; Female; Haloperidol; Humans; Middle Aged; Pituitary Diseases; Syndrome; Thioridazine; Vasopre | 1977 |
Catatonia and malignant syndrome: a possible complication of neuroleptic administration. Report of a case involving haloperidol.
Topics: Adult; Basal Ganglia Diseases; Benztropine; Catatonia; Diagnosis, Differential; Haloperidol; Humans; | 1977 |
Inappropriate ADH secretion.
Topics: Haloperidol; Humans; Schizophrenia; Syndrome; Thioridazine; Vasopressins | 1977 |
Dystonia and tremor in spasmodic torticollis.
Topics: Adult; Age Factors; Aged; Dystonia Musculorum Deformans; Facial Nerve; Female; Haloperidol; Humans; | 1976 |
Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol.
Topics: Adult; Female; Hallucinations; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mal | 1976 |
Clinical and biochemical parameters during neuroleptic treatment. II. Antipsychotic effect of haloperidol in patients with chronic organic brain damage.
Topics: Adult; Aged; Brain Damage, Chronic; Depression; Female; Hallucinations; Haloperidol; Homovanillic Ac | 1976 |
Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs.
Topics: Acute Disease; Adult; Amitriptyline; Benztropine; Chemical Phenomena; Chemistry; Cholinesterase Inhi | 1975 |
Use of pimozide in the Pisa syndrome.
Topics: Adult; Dystonia; Haloperidol; Humans; Male; Pimozide; Receptors, Opioid; Receptors, sigma; Schizophr | 1992 |
[ICU syndrome].
Topics: Aged; Anxiety; Benzodiazepines; Clomipramine; Critical Care; Delirium; Depressive Disorder; Female; | 1991 |
The rabbit syndrome.
Topics: Antipsychotic Agents; Female; Haloperidol; Humans; Male; Middle Aged; Movement Disorders; Schizophre | 1990 |
Dual-respiratory rhythms. A key to diagnosis of diaphragmatic flutter in patients with HVS.
Topics: Adolescent; Adult; Carbon Dioxide; Diaphragm; Electromyography; Female; Haloperidol; Humans; Hyperve | 1989 |
[Structure of the anxious-delusional syndrome of schizophrenic patients during treatment with anxiolytics].
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Benzodiazepinones; Clozapine | 1986 |
Akathisia: the syndrome of motor restlessness.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Diphenhydramine; Haloperidol; Humans; Ma | 1987 |
Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome.
Topics: Animals; Antipsychotic Agents; Anxiety; Corpus Striatum; Defecation; Digestive System; Disease Model | 1987 |
Pisa syndrome. Report of a case.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Schiz | 1988 |
Kluver-Bucy syndrome in Huntington's chorea.
Topics: Adult; Agnosia; Behavior; Dementia; Dopamine; Feeding Behavior; Haloperidol; Humans; Huntington Dise | 1985 |
Pisa syndrome in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amantadine; Drug Therapy, Combination; Dystonia; Haloperidol; Humans; Male; | 1988 |
Paroxysmal myoclonic dystonia with vocalisations: new entity or variant of preexisting syndromes?
Topics: Adolescent; Adult; Child; Diagnosis, Differential; Dystonia; Female; Haloperidol; Humans; Male; Move | 1986 |
[Drug-induced extrapyramidal syndrome. Apropos of 22 cases].
Topics: Adolescent; Antiemetics; Basal Ganglia Diseases; Benzamides; Child; Child, Preschool; Female; Halope | 1987 |
Tourette syndrome, pimozide, and school phobia: the neuroleptic separation anxiety syndrome.
Topics: Antidepressive Agents, Tricyclic; Anxiety, Separation; Child; Haloperidol; Humans; Male; Phobic Diso | 1985 |
[Sudden cessation of psychotropic drugs].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Blood Pressure; Chlorprom | 1974 |
[Diagnosis and treatment of myoclonic syndromes in children].
Topics: Adolescent; Barbiturates; Child; Child, Preschool; Diazepam; Female; Haloperidol; Humans; Male; Myoc | 1973 |
Depression and mania associated with Kleine-Levin-Critchley syndrome.
Topics: Adolescent; Bipolar Disorder; Electroconvulsive Therapy; Electroencephalography; Female; Haloperidol | 1973 |
[Collagenosis-like syndromes as the possible manifestations of poisoning by the components of a compound].
Topics: Adult; Aniline Compounds; Collagen Diseases; Drug Combinations; Epoxy Resins; Female; Humans; Male; | 1995 |